tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
ORTX is currently covered by 5 analysts with an average price target of $67.4. This is a potential upside of $50.7 (303.59%) from yesterday's end of day stock price of $16.7.
Orchard Therapeutics PLC's activity chart (see below) currently has 27 price targets and 31 ratings on display. The stock rating distribution of ORTX is 85.71% BUY and 14.29% HOLD.
Analysts average stock forecasts to be materialized ratio is 30.77% with an average time for these price targets to be met of 102.46 days.
Highest price target for ORTX is $16, Lowest price target is $15, average price target is $67.4.
Most recent stock forecast was given by DAE GON HA from STIFEL on 05-Oct-2023. First documented stock forecast 26-Nov-2018.
Currently out of the existing stock ratings of ORTX, 6 are a BUY (85.71%), 1 are a HOLD (14.29%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
16
$-0.7 (-4.19%)
22
6 months 20 days ago
1/2 (50%)
$0.05 (0.31%)
1
Buy
15
$-1.7 (-10.18%)
15
9 months 29 days ago
2/2 (100%)
$9.77 (186.81%)
146
Buy
10 months 12 days ago
1/2 (50%)
$88 (107.32%)
428
Buy
5
$-11.7 (-70.06%)
1 years 1 months 12 days ago
1/1 (100%)
$0.05 (1.01%)
1
Buy
13
1 years 11 months 12 days ago
1/2 (50%)
$-34.2 (-72.46%)
481
What is ORTX (Orchard Therapeutics PLC) average time for price targets to be met?
Which analyst has the current highest performing score on ORTX (Orchard Therapeutics PLC) with a proven track record?
Which analyst has the most public recommendations on ORTX (Orchard Therapeutics PLC)?
Which analyst is the currently most bullish on ORTX (Orchard Therapeutics PLC)?
Which analyst is the currently most reserved on ORTX (Orchard Therapeutics PLC)?
